MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
NRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurosense Therapeutics (NRSN) Ownership - Who owns Neurosense Therapeutics?

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
16
Web
https://www.neurosense-tx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.05M
P/E Ratio
N/A
Total Cash
666K
Projected Growth
N/A
Total Debt
19K
Revenue
N/A
Risk (Beta)
5.04
Dividend Yield
N/A
Total Cash/Share
0.35
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
NRSN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for NRSN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
16
Web
https://www.neurosense-tx.com
Who owns Neurosense Therapeutics? NRSN symbol Ownership - Tickeron.com